Finding sustainable paths to improved patient outcomes
Sustainability in action
We believe our collective health depends on the health of our planet. That makes environmental responsibility an essential complement to our core mission: advancing patient care through innovation and technology.



What does reprocessing responsibly mean at Medtronic?
Patients inspire our pursuit of innovation — and our mission drives us to put inspiration into action. That’s why we’re taking steps to elevate outcomes for patients, customers, and the environment.
Our trusted vessel sealing technology delivers reliable performance along with uncompromising sustainability.
By removing the black plastic wrap on the shaft of our LigaSure™ blunt tip and Maryland jaw devices, we are able to:
Refer to the IFU for more information on Indications, Contraindictions and Risks.
Experience the freedom of a cordless design while leveraging reusable components to reduce waste.
Better detection leads to earlier intervention, which helps prevent more resource-intensive treatments down the line.
GI Genius™ improves Adenoma Detection Rate (ADR) by up to 14%,7 helping physicians identify polyps they might otherwise miss.
This device is not intended to replace clinical decision making. Refer to the IFU for more information on Indications, Contraindictions and Risks.
BIS™ technology individualizes dosing from beginning to end, helping you make efficient use of OR resources.8–12
By reflecting the anesthetic effect on each patient’s brain to personalize dosing, the BIS™ monitoring system can:
The BIS monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment. Reliance on the BIS monitoring system alone for intraoperative anesthetic management is not recommended.
We’re exploring ways to extend product life by keeping materials and components efficiently circulating within the economy through forward-thinking product design and end-of-life solutions.
The modular design of the intelligent Signia™ stapling system advances material efficiency in linear and circular powered stapling while upholding the highest standards of quality.
Risks may include, but are not limited to: acute/chronic pain, bleeding, infection, and tissue damage. Potential complications may include failure to anastomose, blood loss, ischemia, stenosis, bowel perforation, gastro-intestinal obstruction/occlusion, and tissue breakdown.
The TruClear™ system enables effective procedures#,16–18 while advancing environmentally responsible practices.
Reusable components like the TruClear™ handpiece reduce the need for frequent production and disposal and allow for reduced packaging.
By leveraging the TruClear™ system and HysteroLux™ fluid management you can reduce waste in the OR by:
As with all operative hysteroscopy, adverse effects include but are not limited to intravasation, uterine perforation, exposure to body fluids, laceration, carcinogen exposure, electric shock, and air embolism.
We produce millions of reprocessed Nellcor™ pulse oximetry sensors to extend product life, diverting 500k pounds from the landfill annually.1
The McGRATH™ rechargeable battery system powers the McGRATH™ video laryngoscopes to support higher first-pass success rates22,23 while providing hospitals with long-term cost savings24,25 and lowering the environmental impact of intubation.
Minimalist material use:
For trained personnel only. For specific indications and instructions for use, please refer to the product manual.
We’re committed to developing initiatives meant to minimize customer waste, reduce materials of concern, and shrink the environmental footprint of operations globally.
Medtronic will eliminate 2,500 tons of paper waste by FY30 by moving to eIFUs.
Hugo™ RAS system: Risks may include arrythmia, bleeding, burns, infection, tissue damage, or other complications.
We’ve removed the electric clip counter and lithium battery from Endo Clip™ III devices, instead color-coding the last three clips in the device blue to alert surgeons of low clip count to reduce waste without compromising quality.
This small design change allows us to:
Refer to the IFU for more information on Indications, Contraindictions and Risks.
Our universal trocar platform provides versatility and efficiency34 in one complete solution.
The redesigned packaging configuration on VersaOne™ trocars is made from recycled materials††,35 and results in an 80% reduction in packaging material weight due to the redesigned soft pouch display packaging††,35
Our collections program keeps surgical products out of landfills and ensures responsible management through a certified waste-to-energy facility.
Reprocessing responsibly at Medtronic
The waste impact of medical devices creates a sustainability challenge for healthcare.
Medtronic is
investing in waste reduction through extended product life and end-of-life solutions.1







Reprocessed by Medtronic
Nellcor™ pulse oximetry
Noninvasive products
Noninvasive device: may be safely reprocessed using methodology tested and approved by Medtronic.
Not reprocessed by Medtronic
LigaSure™ vessel sealing devices
Energy-based surgical products
Invasive, high-criticality device designed for single use. No internal data to support reprocessing; collections go to waste-to-energy facility instead of landfill.
Circularity across the portfolio
Innovative offerings that pair the right solutions with the right products
† Trust in LigaSure™ technology is rooted in its globally documented reliable performance.
‡ 25 out of 27 surgeons surveyed after use agreed. 26 out of 27 surgeons surveyed after use agreed. Compared to the Sonicision™ curved jaw device.
§ Mass comparison made with dissector and assembly tool.
◊ Total waste based on device component weights and expected circulation ratio of each component per procedure.
¶ Total waste based on device component weights and expected circulation ratio of each component on a per-procedure basis comparing CDH31P to the Signia™ circular stapler with a 31 mm Tri-Staple™ reload (n = 3, p < 0.001).
# Five cohort studies (n=339) reported IUAs in 22.4% (95% confidence interval, 18.3%–27%) of women hysteroscopically evaluated. Significantly more IUAs were encountered after dilation and curettage (D&C) compared with after hysteroscopic resection (HR): 30% vs. 13%. Incomplete evacuation was encountered in, respectively, 29% and 1% of the D&C and HR cases.
∆ Based on a standardized operation runtime of 10,000 minutes, disposing the McGRATH™ rechargeable battery generate 24.72 grams of waste, while disposing the McGRATH™ disposable batteries generate 1098.5 grams of waste.
∞ Based on in vivo, ex vivo, and benchtop testing. Preclinical results may not correlate with clinical performance in humans. Bench test results may not necessarily be indicative of clinical performance.
†† Based on an analysis of the environmental impact of trocar packaging configurations.